Boston Scientific Passes Baton: Former Zimmer Chief To Replace Tobin
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific's newly appointed CEO Ray Elliott brings a reputation as a cost-cutter with a focus on profitability from his decade-long experience as chief exec at orthopedic firm Zimmer
You may also be interested in...
Ray Elliott Retiring: Is Boston Scientific On Or Off Track?
Ray Elliott's surprise retirement announcement from Boston Scientific last week was to some a warning sign that the company's challenges are even bigger than expected, but the CEO argues it is just the opposite. He says he has accomplished what he came to do.
Ray Elliott Retiring: Is Boston Scientific On Or Off Track?
Ray Elliott's surprise retirement announcement from Boston Scientific last week was to some a warning sign that the company's challenges are even bigger than expected, but the CEO argues it is just the opposite. He says he has accomplished what he came to do.
Boston Scientific Recalls All Implantable Defibrillators, Suspends Sales
Boston Scientific is recalling all lines of its implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators nationwide because the firm made manufacturing process changes without proper FDA approval